Cirrhotic effusion, also known as decompensated cirrhosis, has an average life expectancy of about 5 years, but of course its not absolute and there is significant individual variability. This is because patients with decompensated cirrhosis have associated complications, such as gastrointestinal bleeding, hepatorenal syndrome, hepatic encephalopathy, primary liver cancer, etc. If there is a combination of upper gastrointestinal hemorrhage, it may be life-threatening in a short period of time. Therefore, the life expectancy of patients with decompensated cirrhosis depends mainly on whether they are treated regularly and the efficacy of the treatment. If a patient with decompensated cirrhosis is relatively stable after regular treatment, the survival life expectancy of 5 years is definitely more than that. If the patient repeatedly develops related complications such as hepatic encephalopathy, hepatorenal syndrome, etc., the life expectancy will be significantly shortened.